Rheumatology Search
Rheumatology Rheumatology
gout
GOUT
Gout is a condition that resulted from deposition of monosodium urate crystals in various tissues (eg joints, connective tissue, kidney).
The patient experiences acute and chronic arthritis, soft tissue inflammation, tophus formation, gouty nephropathy and nephrolithiasis.
Primary hyperuricemia is called when uric acid saturation arises without coexisting diseases or drugs that alter uric acid production and excretion.
While in secondary hyperuricemia there is an excessive uric acid production or diminished renal clearance that occurs as a result of a disease, drug, dietary product or toxin.

Definition

  • Gout is a condition wherein there is increased uric acid or urate in the body, also called hyperuricemia, that leads to deposition of monosodium urate monohydrate crystals in various tissues (eg joints, connective tissue, kidney)

Pathophysiology

  • Hyperuricemia is a necessary precondition for the development of monosodium urate monohydrate crystal deposition but this has to be distinguished from gout, the clinical syndrome
  • Results in acute & chronic inflammation associated with changes in articular & periarticular structures

Epidemiology

  • Affects up to 1-2% of adults & is the most common inflammatory arthritis in men
  • Prevalence of gout in the Asia-Pacific region varies
    • Ethnic groups in China & Malaysia (eg Malays, Tamils) were found to have higher uric levels as compared to the Japanese & Thai
    • Taiwan is one of the countries in the world with highest prevalence of gout

Risk Factors

Risk factors for gout & associated comorbidity should be assessed

Risk factors associated with gout:

  • Hyperuricemia
    • Single most important risk factor for developing gout
  • Male sex
  • Menopausal women
  • Age
  • Purine-rich diet (eg meat, seafood)
  • Alcohol intake
  • Diuretic use
  • Other drug use (eg low-dose Aspirin, antihypertensive medications, Ciclosporin)
  • Lead exposure

Metabolic abnormalities associated with gout:

  • Hypertension
  • Obesity
  • Dyslipidemia
  • Hyperglycemia & insulin resistance

Comorbidities associated with gout:

  • Coronary artery disease
  • Type 2 diabetes mellitus
  • Renal insufficiency
  • Metabolic syndrome
  • Kidney stone
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Patients with gastric dysplasia at risk of progression to gastric adenocarcinoma
06 Sep 2019
Gastric dysplasia (GD), specifically high-grade lesions, appears to carry an elevated risk of progression to gastric adenocarcinoma (GAC), according to the results of a meta-analysis.
Beta-blockers may reduce mortality in patients with heart failure, renal dysfunction
Roshini Claire Anthony, 4 days ago

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.
Physician–pharmacist collaborative care improves nb-DMARD dose optimization, adherence
Stephen Padilla, 5 days ago
Implementation of the collaborative care in a rheumatoid arthritis (RA) clinic has led to improvements in nonbiologic disease-modifying antirheumatic drugs (nb-DMARDs) optimization, adherence to safety recommendations on nb-DMARD monitoring and detection of adverse drug events in RA patients, according to a Singapore study.
Vitamin D supplementation may benefit hypercholesterolaemia patients
05 Sep 2019
Supplementation with vitamin D appears to help reduce the serum concentration of total and low-density lipoprotein cholesterol and triglyceride but not high-density lipoprotein cholesterol, suggesting its usefulness for mitigating the risk of cardiovascular disease in patients with hypercholesterolaemia, according to the results of a meta-analysis.